Related Experiment Video
Updated: Jun 8, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
[Cardiovascular consequences of obstructive sleep apnea syndrome]
Geraldo Lorenzi Filho1, Pedro Rodrigues Genta, Rodrigo Pinto Pedrosa
1Disciplina de Pneumologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil. geraldo.lorenzi@incor.usp.br
Abstract:
Obstructive sleep apnea syndrome (OSAS) is a common condition associated with various cardiovascular diseases, including systemic arterial hypertension, atrial fibrillation, and atherosclerosis. The association between OSAS and cardiovascular disease has been related to the overlapping of risk factors, including obesity, having a sedentary lifestyle, being male, and being older. However, there is mounting evidence that OSAS can also independently contribute to the development and progression of various cardiovascular diseases. The mechanisms by which OSAS can affect the cardiovascular system are multiple, including the activation of the sympathetic nervous system, systemic inflammation, insulin resistance, and oxidative stress. There is also evidence that the treatment of OSAS with CPAP can reduce arterial blood pressure, early signs of atherosclerosis, the risk of atrial fibrillation recurrence, and mortality (principally mortality due to stroke or acute myocardial infarction) in patients with severe OSAS.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Other Pulmonary Disorders
Hypertension II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Heart Failure VI: Adjunct Therapies

